Markus Heim

Markus Heim

Universität Basel

H-index: 79

Europe-Switzerland

About Markus Heim

Markus Heim, With an exceptional h-index of 79 and a recent h-index of 46 (since 2020), a distinguished researcher at Universität Basel, specializes in the field of Hepatology, Hepatocellular Carcinoma, Virology, Innate Immunity, Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

978 Loss of heterozygosity in CYP2D6 locus sensitises cancer cells to talazoparib

Distinct circulating monocytes up-regulate CD52 and sustain innate immune function in patients with cirrhosis unless acute decompensation emerges

Targeting the expansion of myeloid-derived suppressor cells in liver cirrhosis

Loss of CYP2D6 sensitizes hepatocellular carcinomas and neuroblastomas to talazoparib

Inflammation-induced TRIM21 represses hepatic steatosis by promoting the ubiquitination of lipogenic regulators

Author Correction: Bipotent transitional liver progenitor cells contribute to liver regeneration

Arginine reprograms metabolism in liver cancer via RBM39

Bipotent transitional liver progenitor cells contribute to liver regeneration

Markus Heim Information

University

Position

Professor of Medicine Switzerland

Citations(all)

25619

Citations(since 2020)

7800

Cited By

20855

hIndex(all)

79

hIndex(since 2020)

46

i10Index(all)

179

i10Index(since 2020)

132

Email

University Profile Page

Universität Basel

Google Scholar

View Google Scholar Profile

Markus Heim Skills & Research Interests

Hepatology

Hepatocellular Carcinoma

Virology

Innate Immunity

Oncology

Top articles of Markus Heim

Title

Journal

Author(s)

Publication Date

978 Loss of heterozygosity in CYP2D6 locus sensitises cancer cells to talazoparib

Xiaonan Zhang

Natallia Rameika

Lei Zhong

Veronica Rendo

Snehangshu Kundu

...

2024/3/1

Distinct circulating monocytes up-regulate CD52 and sustain innate immune function in patients with cirrhosis unless acute decompensation emerges

bioRxiv

Anne Geng

Robert Georg Brenig

Julien Roux

Mechthild Luetge

Hung-Wei Cheng

...

2024

Targeting the expansion of myeloid-derived suppressor cells in liver cirrhosis

bioRxiv

Emilio Eric Flint

Caner Ercan

Eoin Mitchell

Oltin Tiberiu Pop

Anne Geng

...

2024

Loss of CYP2D6 sensitizes hepatocellular carcinomas and neuroblastomas to talazoparib

Tobias Sjöblom

Xiaonan Zhang

Natallia Rameika

Lei Zhong

Verónica Rendo

...

2023/8/21

Inflammation-induced TRIM21 represses hepatic steatosis by promoting the ubiquitination of lipogenic regulators

JCI insight

Kostas C Nikolaou

Svenja Godbersen

Muthiah Manoharan

Stefan Wieland

Markus H Heim

...

2023/11/11

Author Correction: Bipotent transitional liver progenitor cells contribute to liver regeneration

nature genetics

Wenjuan Pu

Huan Zhu

Mingjun Zhang

Monika Pikiolek

Caner Ercan

...

2023/5

Arginine reprograms metabolism in liver cancer via RBM39

Cell

Dirk Mossmann

Christoph Müller

Sujin Park

Brendan Ryback

Marco Colombi

...

2023/11/9

Bipotent transitional liver progenitor cells contribute to liver regeneration

Nature Genetics

Wenjuan Pu

Huan Zhu

Mingjun Zhang

Monika Pikiolek

Caner Ercan

...

2023/4

Canagliflozin and metabolic associated fatty liver disease in patients with diabetes mellitus: new insights from CANVAS

The Journal of Clinical Endocrinology & Metabolism

Angel N Borisov

Alexander Kutz

Emanuel R Christ

Markus H Heim

Fahim Ebrahimi

2023/11

AXL expression on homeostatic resident liver macrophages is reduced in cirrhosis following GAS6 production by hepatic stellate cells

Cellular and molecular gastroenterology and hepatology

Oltin-Tiberiu Pop

Anne Geng

Emilio Flint

Arjuna Singanayagam

Caner Ercan

...

2023/1/1

2307P Loss of CYP2D6 activity sensitizes liver cancer cells to chemotherapy

Annals of Oncology

N Rameika

X Zhang

L Zhong

V Rendo

S Kundu

...

2023/10/1

Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics

Journal of Hepatology

Sarp Uzun

Carl P Zinner

Amke C Beenen

Ilaria Alborelli

Ewelina M Bartoszek

...

2023/9/1

Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis

Molecular cell

Sujin Park

Dirk Mossmann

Qian Chen

Xueya Wang

Eva Dazert

...

2022/11/17

Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma

Molecular oncology

John Gallon

Mairene Coto‐Llerena

Caner Ercan

Gaia Bianco

Viola Paradiso

...

2022/2

Impact of propofol sedation on the diagnostic accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis

Hepatology International

Fahim Ebrahimi

David Semela

Markus Heim

2022/8/1

Studying hepatitis virus-host interactions in patient liver biopsies

Aleksei Suslov

Markus H Heim

Stefan Wieland

2022/11/10

Computed tomography (CT) and magnetic resonance imaging (MRI) of diffuse liver disease: a multiparametric predictive modelling algorithm can aid categorization of liver parenchyma

Quantitative Imaging in Medicine and Surgery

Ricardo Donners

Carmen Zaugg

Julian E Gehweiler

Tuyana Boldanova

Markus H Heim

...

2022/2

Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report

Communications Medicine

Marie-Anne Meier

Sandro Nuciforo

Mairene Coto-Llerena

John Gallon

Matthias S Matter

...

2022/7/1

A novel patient-derived model to study cellular plasticity and drug response in sarcomatoid urothelial bladder cancer

European Urology Open Science

M Garioni

L Blukacz

S Nuciforo

L Roma

S Piscuoglio

...

2022/10/1

Human-correlated genetic HCC models identify combination therapy for precision medicine

Miryam Müller

Stephanie May

Holly Hall

Timothy J Kendall

Lynn McGarry

...

2022/5/12

See List of Professors in Markus Heim University(Universität Basel)